![](/wp-content/uploads/2023/11/Screenshot-2023-11-13-at-2.36.44-PM.png)
$599
Galectin and Akero Q3 ’23 Earnings; 89bio Presents Additional MASH Data at AASLD 2023; Dario Announces New Integrated Cardiometabolic Solution Research
Four cardiometabolic-related news items have been observed from Galectin, Akero, 89bio, and Dario. Below, FENIX provides highlights and insights from the respective news items.